title: Personalized medicine and disruptive innovation: implications for technology assessment.
authors.affiliation: Duke Clinical Research Institute, Duke Translational Medicine Institute, Durham, North Carolina, USA. kevin.schulman@duke.edu
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Schulman
authors.forename: Ana Valverde
authors.initials: AV
authors.lastname: Vidal
authors.forename: D Clay
authors.initials: DC
authors.lastname: Ackerly
mesh_terms: D003695:Delivery of Health Care / Q000379:methods / Q000639:trends; D004059:Diffusion of Innovation; D006801:Humans; D033181:Information Dissemination / Q000379:methods*; D010548:Personal Health Services / Q000379:methods*; D013673:Technology Assessment, Biomedical / Q000379:methods